ImpediMed and Metagenics Announce Agreement
"We've seen the synergies of combining ImpediMed's products for assessing fat and fluid status with our own research-based health and wellness products and programs, which we market to healthcare professionals," said Mike Katke, VP of Medical Marketing for San Clemente, California-based Metagenics. "Their scientifically-grounded approach and the reliability and portability of their technology made offering ImpediMed to our customers a simple decision."
ImpediMed CEO Greg Brown said, "Metagenics has been an outstanding Australian partner using ImpediMed's body composition analysis devices for several years. This expanded relationship makes sense in light of our mutual focus on addressing wellness and healthier life styles."
About Metagenics, Inc.
Metagenics, Inc. is a life sciences company and leading developer and manufacturer of science-based nutraceuticals medical foods, and therapeutic lifestyle change programs marketed to healthcare practitioners worldwide. It is headquartered in San Clemente, Calif. with manufacturing and multiple research facilities located in Gig Harbor, Wash., including its MetaProteomics(R) Nutrigenomics Research Center and its Functional Medicine Research Center(SM) for human clinical research. Metagenics holds multiple proprietary formula patents and produces over 400 research-based products to optimize health. The company demonstrates its commitment to purity and quality through its certifications for Good Manufacturing Practices (GMP) from the NPA, NSF International, and TGA. For more information about Metagenics, please visit www.metagenics.com.
About ImpediMed Limited
ImpediMed Limited develops and globally markets medical device systems for use in non-invasive screening and monitoring of fluid status and body composition. ImpediMed's product range includes medical devices for body composition analysis and early detection and monitoring of secondary lymphedema in cancer survivors. ImpediMed's products are TGA and FDA cleared as well as CE marked for global distribution. For more information about ImpediMed, please visit www.impedimed.com
Contact: Joseline Davison Metagenics, Inc. 949-369-3406 email@example.com Jack Butler ImpediMed 585-248-2554 firstname.lastname@example.org
SOURCE ImpediMed Ltd
You May Also Like